SMTL ID : 5cal.1

EGFR kinase domain mutant "TMLR" with compound 24

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x 4Z8: 2,2-dimethyl-3-[(4-{[2-methyl-1-(propan-2-yl)-1H-imidazo[4,5-c]pyridin-6-yl]amino}pyrimidin-2-yl)amino]propanamide(Non-covalent)

4Z8.1: 16 residues within 4Å: Chain A: L.25, F.30, V.33, A.50, K.52, C.82, M.97, Q.98, L.99, M.100, G.103, R.148, N.149, L.151, T.161, D.162 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:F.30, A:V.33, A:V.33, A:M.97, A:L.151 Hydrogen bonds: A:Q.98, A:M.100, A:N.149

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Heald, R. et al., Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study. J.Med.Chem. (2015)

Release Date

2015-10-28

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence